Advanced search
Publication Cover
Current Eye Research Volume 12, 1993 - Issue 4
Submit an article Journal homepage
80
Views
39
CrossRef citations to date
0
Altmetric
Original Article

Safety and efficacy of loteprednol etabonate for treatment of papillae in contact lens-associated giant papillary conjunctivitis

Jimmy D. Bartlett Department of Optometry, School of Optometry, University of Alabama at Birmingham, USA
,
John F. Howes Department of Optometry, School of Optometry, Pharmos Corporation, Alachua, FL, USA
,
N. Rex Ghormley Department of Optometry, School of Optometry, St Louis, MO, USA
,
John F. Amos Department of Optometry, School of Optometry, University of Alabama at Birmingham, USA
,
Robert Laibovitz Department of Optometry, School of Optometry, Austin, TX, USA
&
Barry Horwitz Department of Optometry, School of Optometry, Houston, TX, USA
Pages 313-321 | Received 13 Oct 1992, Accepted 01 Mar 1993, Published online: 02 Jul 2009

References

  • Jaanus S. D. Anti‐inflammatory drugs. Clinical Ocular Pharmacology2nd ed., J. D. Bartlett, S. D. Jaanus. Butterworth Publishers, Boston 1989; 163–197
  • Becker B. The side effects of corticosteroids. Invest. Ophthalmol. 1964; 3: 492–497
  • Bodor N. The application of soft drug approaches to the design of safer corticosteroids. Topical Corticosteroid Therapy: A Novel Approach to Safer Drugs, E. Christophers. Raven Press, Ltd., New York 1988; 13–25
  • Bodor N. Designing safer ophthalmic drugs. Trends in Medicinal Chemistry ′88, H. Van der Goot, G. Domany, L. Pallow, H. Timmernan. Elsevier Science Publishers, Amsterdam 1988; 145–164
  • Bodor N. Novel approaches to the design of safer drugs: Soft drugs and site‐specific chemical delivery systems. Advances in Drug Research. Academic Press, London 1984; 255–331
  • Bodor N. Soft drug principles and methods for the design of safe drugs. Med. Res. Rev. 1984; 4: 449–469
  • Allansmith M. R., Korb D. R., Greiner J. V. Giant papillary conjunctivitis in contact lens wearers. Am. J. Ophthalmol. 1977; 83: 697–708
  • Allansmith M. R., Ross R. N. Ocular allergy and mast cell stabilizers. Surv. Ophthalmol. 1986; 30: 229–244
  • Allansmith M. R. Giant papillary conjunctivitis. J. Am. Optom. Assoc. 1990; 61: S42–S46, (Suppl)
  • Wood T. S., Stewart R. H., Bowman R. W., McCulley J. P., Reaves T. A. Suprofen treatment of contact lens‐associated giant papillary conjunctivitis. Ophthalmology 1988; 95: 822–826
  • Yeh C. (1990) Estimation and significance tests of area under the curve derived from incomplete blood sampling. ASA Proceedings of Biopharmaceutical Section. 1990. American Statistical Association, Alexandria, Virginia, 74–81
  • Donshik P. C., Ballow M., Luistro A. Treatment of contact lens‐induced giant papillary conjunctivitis. C.L.A.O. J. 1984; 10: 346–349
  • Druzgala P. D., Wu W. M., Winwood D., Howes J. F., Reaves T. A. Ocular absorption and distribution of loteprednol etabonate: A “soft” steroid. Invest. Ophthalmol. Vis. Sci. 1991; 32: 735, (Suppl)
  • Lee V. H., Iimoto D. S., Takemoto K. A. Subcellular distribution of esterases in the bovine eye. Curr. Eye Res. 1982; 2: 869–876
  • Lee V. H., Smith R. E. Effect of substrate concentration, product concentration and peptides on the in vitro hydrolysis of model ester prodrugs by corneal esterases. J. Ocular Pharmacol. 1985; 1: 269–278
  • Tsuji A., Tanai I., Sasaki K. Hydrolysis of prednisolone succinate by esterases in rabbit ocular tissue. Ophthalmic Res. 1987; 19: 322–329
  • Leibowitz H. M., Kupferman A., Ryan W. J., Reaves T. A., Howes J. Corneal anti‐inflammatory efficacy of loteprednol etabonate: A new steroidal soft drug. Invest. Ophthalmol. Vis. Sci. 1991; 32: 735, (Suppl)
  • Keates E. U., Druzgala P. D., Howes J. F., Reaves T. A. Loteprednol etabonate: A new steroid without ocular hypertensive effect. Invest. Ophthalmol. Vis. Sci. 1991; 32: 947, (Suppl)
  • Armaly M. F. Statistical attributes of the steroid hypertensive response in the clinically normal eye. I. The demonstration of 3 levels of response. Invest. Ophthalmol. 1965; 4: 187–197
  • Becker B. Intraocular pressure response to topical corticosteroids. Invest. Ophthalmol. 1965; 4: 198–205
  • Bartlett J. D., Horwitz B., Laibovitz R., Howes J. F. Intraocular pressure response to loteprednol etabonate in known steroid responders. J. Ocular Pharmacol. (accepted) 1993

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.